Back to NRSNW

CITADEL ADVISORS LLC → NRSNW

CITADEL ADVISORS LLC NRSNW Position History

NeuroSense Therapeutics Ltd. • Healthcare

Quarters held
11
Latest value
$282K
Q2 2025
Peak value
$305K
First seen
Q1 2023

Dollar value over time

Show data table
PeriodPosition value
Q1 2023$10K
Q2 2023$9K
Q3 2023$9K
Q3 2023$2K
Q1 2024$20K
Q2 2024$6K
Q3 2024$44K
Q3 2024$4K
Q4 2024$305K
Q4 2024$7K
Q2 2025$282K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2025$282K149.2K——
Q4 2024$7K22.7K——
Q4 2024$305K254.0K——
Q3 2024$4K25.3K——
Q3 2024$44K34.3K——
Q2 2024$6K29.5K——
Q1 2024$20K48.1K——
Q3 2023$2K11.6K——
Q3 2023$9K11.7K——
Q2 2023$9K37.9K——
Q1 2023$10K32.6K——

Other funds holding NRSNW

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B